Effects of dose modifications on the safety and efficacy of dacomitinib for mutation-positive non-small-cell lung cancer

  1. Corral, J.
  2. Mok, T.S.
  3. Nakagawa, K.
  4. Rosell, R.
  5. Lee, K.H.
  6. Migliorino, M.R.
  7. Pluzanski, A.
  8. Linke, R.
  9. Devgan, G.
  10. Tan, W.
  11. Quinn, S.
  12. Wang, T.
  13. Wu, Y.-L.
Journal:
Future Oncology

ISSN: 1744-8301,  1479-6694

Year of publication: 2019

Volume: 15

Issue: 24

Pages: 2795-2805

Type: Article

DOI: 10.2217/FON-2019-0299 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus